News-Medical - Dr. Jawad Ahmad and Dr. Joseph Odin: “Mount Sinai Physician-Scientists Join DILIN to Help Find Causes, Diagnostics for Drug-Induced Liver Injury”

New York, NY
 – September 12, 2013  –– 

In an effort to better understand and develop prevention strategies for drug-induced liver injury (DILI), physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network (DILIN), a National Institutes of Health-funded consortium of only six academic medical centers in the United States. Mount Sinai is the only center in the Northeast participating in the DILIN. The Division of Liver Diseases at Mount Sinai is the latest center to join the DILIN, with Jawad Ahmad, MD, and Joseph Odin, MD, PhD, both Associate Professors of Medicine, as principal investigators. Also joining is the Department of Genetic and Genomic Sciences, chaired by Eric Schadt, PhD, who is also the Director of the Icahn Institute for Genomics and Multiscale Biology, and the Jean C. and James W. Crystal Professor of Genomics. 
Learn more